We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Opko Health Inc | NASDAQ:OPK | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -1.54% | 1.28 | 1.27 | 2.25 | 1.35 | 1.29 | 1.32 | 4,487,673 | 05:00:10 |
|
Delaware
|
|
001-33528
|
|
75-2402409
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
4400 Biscayne Blvd.
|
Miami,
|
Florida
|
|
33137
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Not Applicable
|
Former name or former address, if changed since last report
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.01 per share
|
OPK
|
NASDAQ Global Select Market
|
Emerging growth company
|
☐
|
|
ITEM 5.07.
|
|
Submission of Matters to a Vote of Security Holders.
|
1.
|
All nine nominees were elected to the Board of Directors with each director receiving votes as follows:
|
Election of Directors
|
|
|
For
|
|
Withheld
|
|
Broker Non-Votes
|
|
|
|
|
|
|
|
|
|
|
Phillip Frost, M.D.
|
|
381,793,595
|
|
16,376,829
|
|
|
146,629,158
|
|
Jane H. Hsiao, Ph.D.
|
|
358,503,157
|
|
39,667,267
|
|
|
146,629,158
|
|
Steven D. Rubin
|
|
350,453,143
|
|
47,717,281
|
|
|
146,629,158
|
|
Robert S. Fishel, M.D.
|
|
391,922,739
|
|
6,247,685
|
|
|
146,629,158
|
|
Richard M. Krasno, Ph.D.
|
|
382,493,647
|
|
15,676,777
|
|
|
146,629,158
|
|
Richard A. Lerner, M.D.
|
|
361,304,483
|
|
36,865,941
|
|
|
146,629,158
|
|
John A. Paganelli
|
|
355,000,358
|
|
43,170,066
|
|
|
146,629,158
|
|
Richard C. Pfenniger, Jr.
|
|
375,075,771
|
|
23,094,653
|
|
|
146,629,158
|
|
Alice Lin-Tsing Yu, M.D., Ph.D.
|
|
382,834,580
|
|
15,335,844
|
|
|
146,629,158
|
2.
|
The stockholders voted to approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company as disclosed in the Company’s 2020 Proxy Statement for the Annual Meeting. The votes on this proposal were as follows:
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
|
|
|
|
|
|
|
375,947,339
|
|
20,611,221
|
|
1,611,770
|
|
146,629,158
|
3.
|
The stockholders voted to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020. The votes on this proposal were as follows:
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
|
|
|
|
|
|
|
540,008,637
|
|
3,433,873
|
|
1,180,971
|
|
0
|
ITEM 7.01.
|
|
Regulation FD Disclosure.
|
ITEM 9.01.
|
|
Financial Statements and Exhibits.
|
|
(d)
|
Exhibits
|
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Transcript of OPKO Health, Inc. 2020 Annual Meeting of Stockholders held June 25, 2020.
|
|
|
|
104
|
|
Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
|
|
|
|
|
|
OPKO Health, Inc.
|
|
|
|
|
|
|
|
By:
|
/s/ Steven D. Rubin
|
Date: June 26, 2020
|
|
Name:
|
Steven D. Rubin
|
|
|
Title:
|
Executive Vice President - Administration
|
|
|
|
|
1 Year Opko Health Chart |
1 Month Opko Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions